We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+24.59%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.9B
AUM Growth
+$12.2B
(+25%)
Cap. Flow
+$2B
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
3,213
New
281
Increased
1,628
Reduced
1,147
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$134M |
| 2 |
Microsoft
MSFT
|
+$119M |
| 3 |
Apple
AAPL
|
+$87.6M |
| 4 |
AbbVie
ABBV
|
+$61.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$92.9M |
| 2 |
RTN
Raytheon Company
RTN
|
+$71.6M |
| 3 |
CY
Cypress Semiconductor
CY
|
+$23.6M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$12.9M |
| 5 |
Domino's
DPZ
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.43% |
| 2 | Healthcare | 14.28% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Communication Services | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVFM
2776
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $190K | ﹤0.01% |
4,473
+3,749
| +518% | +$253K |
|
2777
Mid Penn Bancorp
MPB
$952M
| $189K | ﹤0.01% |
10,264
-2,595
| -20% | -$48.8K |
|
2778
Unity Bancorp
UNTY
$599M
| $189K | ﹤0.01% |
13,203
-2,000
| -13% | -$27.4K |
|
|
ASAP
2779
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
| $189K | ﹤0.01% |
3,602
-492
| -12% | -$18.9K |
|
|
WLL
2780
DELISTED
Whiting Petroleum Corporation
WLL
| $189K | ﹤0.01% |
2,235
-2,274
| -50% | -$177K |
|
2781
Century Casinos
CNTY
$34M
| $188K | ﹤0.01% |
45,255
+3,145
| +7% | +$13.2K |
|
2782
The Joint Corp
JYNT
$119M
| $187K | ﹤0.01% |
12,250
+600
| +5% | +$7.86K |
|
|
VTLE
2783
DELISTED
Vital Energy
VTLE
| $186K | ﹤0.01% |
13,404
-17,475
| -57% | -$273K |
|
|
AWH
2784
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $186K | ﹤0.01% |
+3,226
| New | +$215K |
|
|
IIN
2785
DELISTED
IntriCon Corporation
IIN
| $186K | ﹤0.01% |
13,748
+3,500
| +34% | +$44.6K |
|
|
CASI
2786
DELISTED
CASI Pharmaceuticals
CASI
| $185K | ﹤0.01% |
7,403
+847
| +13% | +$18.4K |
|
|
GPX
2787
DELISTED
GP Strategies Corp.
GPX
| $185K | ﹤0.01% |
21,571
+1,965
| +10% | +$14.1K |
|
|
ICAD
2788
DELISTED
iCAD Inc
ICAD
| $184K | ﹤0.01% |
+18,415
| New | +$199K |
|
2789
Lands' End
LE
$403M
| $184K | ﹤0.01% |
22,833
+2,670
| +13% | +$19.2K |
|
2790
LiveOne
LVO
$58.2M
| $184K | ﹤0.01% |
5,092
+1,356
| +36% | +$37.9K |
|
|
NESR
2791
National Energy Services Reunited Corp
NESR
$2.93B
| $184K | ﹤0.01% |
26,765
+1,490
| +6% | +$7.99K |
|
2792
South Plains Financial
SPFI
$841M
| $183K | ﹤0.01% |
12,876
+520
| +4% | +$6.79K |
|
2793
Stereotaxis
STXS
$141M
| $182K | ﹤0.01% |
+40,829
| New | +$165K |
|
2794
X4 Pharmaceuticals
XFOR
$460M
| $182K | ﹤0.01% |
+652
| New | +$179K |
|
2795
Geospace Technologies
GEOS
$75.7M
| $181K | ﹤0.01% |
24,090
-18,229
| -43% | -$121K |
|
2796
Comstock Resources
CRK
$3.94B
| $179K | ﹤0.01% |
40,974
+11,206
| +38% | +$66.9K |
|
2797
Pulse Biosciences
PLSE
$3.02B
| $177K | ﹤0.01% |
16,912
+2,515
| +17% | +$22.6K |
|
2798
Algonquin Power & Utilities
AQN
$4.42B
| $176K | ﹤0.01% |
+13,596
| New | +$186K |
|
|
FARM
2799
DELISTED
Farmer Brothers
FARM
| $176K | ﹤0.01% |
24,038
+7,192
| +43% | +$57.8K |
|
2800
First Bank
FRBA
$454M
| $176K | ﹤0.01% |
26,981
-8,105
| -23% | -$57.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2020 Portfolio in Review
As of Q2 2020, RhumbLine Advisers held 3,213 positions worth $59.9B, up 25% from $47.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers deployed $2B of net new capital in Q2 2020, opening 281 new positions and adding to 1,628 existing holdings. Its largest new stake was Otis Worldwide: 701,378 shares worth $39.9M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $12.9M trimmed.
- RhumbLine Advisers's largest Q2 2020 buy was Otis Worldwide: 701,378 shares worth $39.9M.
- RhumbLine Advisers added most to Amazon in Q2 2020, an estimated $134M increase.
- RhumbLine Advisers's biggest Q2 2020 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $12.9M.
- RhumbLine Advisers fully exited Allergan plc in Q2 2020, selling an estimated $92.9M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $59.9B portfolio in Q2 2020.
- RhumbLine Advisers opened 281 new positions and closed 147 in Q2 2020.
- RhumbLine Advisers's portfolio value rose 25% quarter-over-quarter to $59.9B.
Based on RhumbLine Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.